another imminent ii

When I read the previous thread title, I thought it was referring to the cowen presentation. But no... so I'll to talk about it instead.

Under "Multiple HyACT oncology trials", they refer to "other trials" in addition to the mCRC PhIII and SCLC PhII.

Have I missed something? Are they planning a start to PhII for HA-Doxorubicin or HA-5FU?

Personally, I rather know about this "imminent ii" than rehash last year's endless venting. I think the point has been made ad nauseum.

And before getting into the false dichotomy of "positive" vs "negative" posters, you don't need to sit in one camp or the other to be tired of a repetitive argument.